• Users Online: 269
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
ORIGINAL ARTICLE
Year : 2015  |  Volume : 35  |  Issue : 2  |  Page : 69-74

Estimation of the serum level of a proliferation-inducing ligand in patients with psoriasis and lichen planus


1 Department of Dermatology and Venereology, Faculty of Medicine, Tanta University and Ministry of Health, Tanta, Egypt
2 Department of Medical Biochemistry, Faculty of Medicine, Tanta University and Ministry of Health, Tanta, Egypt

Correspondence Address:
Amal A El-Ashmawy
Assistant Prof. of Dermatology and Venereology, Faculty of Medicine, Tanta University, Tanta
Egypt
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/1110-6530.178465

Rights and Permissions

Background A proliferation-inducing ligand (APRIL) is a new member of the tumor-necrosis factor superfamily. Elevated serum APRIL level has been found in some autoimmune diseases. APRIL costimulates B cells in vitro and in vivo. In addition, APRIL also has an important role in T-cell activation and survival. Objective The aim of the present study was to determine the serum level of APRIL in patients with psoriasis and lichen planus (LP) to evaluate its role in the pathogenesis of both diseases. Patients and methods This study included 40 patients with psoriasis (group II), 40 patients with LP (group III), and 20 healthy individuals who served as controls (group I). Serum samples were taken from all patients and controls for the detection of serum APRIL level by using the enzyme-linked immunosorbent assay. Results A significant increase was found in the mean serum APRIL level in patients with psoriasis and LP when compared with controls. Serum APRIL level was significantly correlated with severity of psoriasis, as determined by the psoriasis area and severity index score. Conclusion APRIL could be implicated as an important cytokine in the pathogenesis of psoriasis and LP. APRIL could be used as a useful marker for assessing psoriasis severity and open the way for further therapeutic approaches for both diseases.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1173    
    Printed50    
    Emailed0    
    PDF Downloaded125    
    Comments [Add]    

Recommend this journal